Short stature is associated with abnormalities of the growth hormone (GH) axis. We hypothesized that an aberrant, less functional, GH molecule due to a growth hormone gene (GH-I) mutation may lead to short stature due to abnormal secretory dynamics or abnormal interaction with the GH receptor. Genomic DNAs from patients (n = 130) with short stature (height < 2 S.D. below mean for age) and normal statured subjects (n = 108) were screened for abnormalities in the coding region of GH-I. The coding region was amplified from genomic DNA by polymerase chain reaction, and assayed by solution hybridization/nuclease protection. Five patients with short stature were identified with point mutations of GH-I in exon 2 compared to none in the normal statured group (p = 0.048). On Southern blotting, the mutation in all five patients created a new HincII restriction site, as evidenced by disappearance of the expected 6.6 Kb band in 3 of 5 patients and appearance of a new 4.5 Kb band in all 5 patients. The exact nature of these mutations will be characterized and studied for their biological activity. The assay described here identifies GH-I mutations in children with short stature which may impact GH function.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Counts, D., Palese, T., Chalew, S. et al. GROWTH HORMONE GENE MUTATIONS IN PATIENTS WITH SHORT STATURE. 505. Pediatr Res 39 (Suppl 4), 87 (1996). https://doi.org/10.1203/00006450-199604001-00525
Issue Date:
DOI: https://doi.org/10.1203/00006450-199604001-00525
- Springer Nature America, Inc.